PTC Therapeutics Stock Predictions

Invest. Do Good. Get Rewarded. Just $0.25/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Sell

PTCT
PTC Therapeutics

Last Price:

42.92

Seasonality Move:

23.53%

7 Day Trial

ALL ACCESS PASS

$ 7

Start Investing Smarter Unlock Louis Navellier's Stock Grader for free

Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.

PTC Therapeutics Stock Forecast

Over the next 52 weeks, PTC Therapeutics has on average historically risen by 28% based on the past 11 years of stock performance.
PTC Therapeutics has risen higher in 7 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 63.64%
Is PTC Therapeutics Stock Undervalued?
The current PTC Therapeutics [PTCT] share price is $42.89. The Score for PTCT is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
PTCT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will PTC Therapeutics Stock Go Up Next Year?

Over the next 52 weeks, PTC Therapeutics has on average historically risen by 28% based on the past 11 years of stock performance.

PTC Therapeutics Stock Rating

Sell

PTC Therapeutics (PTCT) is a Sell

Is PTC Therapeutics overpriced?

PTC Therapeutics has risen higher in 7 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 63.64%

PTC Therapeutics Stock Price History

Is PTCT stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTCT is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

ptcbio.com

52-Week Data

52-Week High:

46.98

52-Week Low:

20.75

Prediction Charts

Market Cap:

3.31B

Price in USD:

42.89

Volume:

599.1K

Beta:

0.84

Technical Analysis

SMA50:

39.03

SMA100:

35.97

SMA200:

33.46

52-Wk Change:

96.29%

Stock Predictions

Is PTC Therapeutics stock public?
Yes, PTC Therapeutics is a publicly traded company.
What is the PTC Therapeutics stock quote today?
The PTC Therapeutics stock price is 42.89 USD today.
How to buy PTC Therapeutics stock online?
You can buy PTC Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Nov-4	39.99	40.39	41.32	39.41
Nov-5	40.36	40.87	41.08	39.89
Nov-6	42.49	43.17	43.27	41.70
Nov-7	43.33	42.96	44.56	42.82
Nov-8	45.64	44.32	46.55	43.64
Nov-11	44.46	44.87	46.98	44.46
Nov-12	44.28	44.62	44.87	43.48
Nov-13	44.68	44.05	45.65	43.55
Nov-14	44.28	42.38	44.28	41.95
Nov-15	42.74	39.23	42.74	38.94
Nov-18	39.14	39.23	39.86	38.65
Nov-19	39.36	39.36	40.06	38.71
Nov-20	39.38	41.96	42.79	38.26
Nov-21	42.09	42.89	43.41	41.21

PTC Therapeutics Earnings

PTC Therapeutics Earnings Report: Per Share PTC Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

PTC Therapeutics Forecast Revenue Growth

PTC Therapeutics Stock Analysis: Historical quarterly revenues per share for PTC Therapeutics and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $1.36 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.03 per share, and an increase next year of $0.55 per share.

* PTC Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.